Page last updated: 2024-10-31

moxisylyte and Flaccid Quadriplegia

moxisylyte has been researched along with Flaccid Quadriplegia in 3 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mathias, CJ2
Unwin, RJ2
Pike, FA1
Frankel, HL2
Sever, PS1
Peart, WS2
Corbett, JL1
Eidelman, BH1

Trials

1 trial available for moxisylyte and Flaccid Quadriplegia

ArticleYear
The immediate pressor response to saralasin in man: evidence against sympathetic activation and for intrinsic angiotensin II-like myotropism.
    Clinical science (London, England : 1979), 1984, Volume: 66, Issue:5

    Topics: Adult; Aldosterone; Blood Pressure; Female; Heart Rate; Humans; Male; Moxisylyte; Muscle, Smooth, Va

1984

Other Studies

2 other studies available for moxisylyte and Flaccid Quadriplegia

ArticleYear
Renal vascular responses to saralasin in conscious chemically denervated rabbits and patients with tetraplegia.
    Clinical and experimental hypertension. Part A, Theory and practice, 1986, Volume: 8, Issue:6

    Topics: Adult; Angiotensin II; Animals; Consciousness; Female; Glomerular Filtration Rate; Guanethidine; Hum

1986
Studies on cerebral circulation in man indicating presence of neurogenic control.
    Proceedings of the Australian Association of Neurologists, 1973, Volume: 9

    Topics: Adult; Blood Pressure; Blood Vessels; Brain; Carbon Dioxide; Cerebrovascular Circulation; Constricti

1973